Skip to main content
Screener/Healthcare/Drug Manufacturers - General

BIIB — Biogen Inc.

NASDAQ
$192.46+1.03 (+0.54%)
S&P 500Large CapHealthcareLow BetaLow P/E
$115.25
$202.41
$189.50
$195.20
EPS (TTM)$155.59
P/E Ratio1.24
Dividend Yield—
Market Cap$28.25B
Volume526K
Prev Close$191.38
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$2.5B$319.5M$148.400.0%12.9%
Q4 '25$2.3B-$48.4M$-0.3378.2%-2.1%
Q3 '25$2.5B$466.5M$3.1764.3%19.0%
Q2 '25$2.6B$634.8M$4.3564.2%24.0%
Q1 '25$2.4B$240.5M$1.6476.2%9.9%
Q4 '24$2.5B$266.7M$1.8376.2%10.9%
Q3 '24$2.5B$388.5M$2.6674.1%15.8%
Q2 '24$2.5B$583.6M$4.0061.2%23.7%
Get Your Daily Market Recap